CYP2C19 STATUS AND OUTCOMES IN THE EUCLID TRIAL

Cytochrome P450 2C19 (CYP2C19) is a hepatic enzyme involved in metabolism of clopidogrel to its active metabolite. Polymorphisms with 2 loss-of-function (LOF) alleles lead to poor metabolism of clopidogrel, but little is known about the effects of both heterozygous state for LOF and gain-of-function